The following protocol has been optimized for AAV8 vectors. Minor modifications may be needed for other serotypes.
For each AAV vector:
- Grow five 15-cm plates of 293T cells. Await 80-90% confluency.
- Mix Helper (100ug), Rep2/Cap8 (35ug), and AAV vector (35ug) plasmids in a 50mL tube.
- Add 25mL of plain DMEM to the 50mL tube.
- Add 680ul polyethyleneimine (PEI) transfection reagent to the 50mL tube. Mix by inversion and incubate for 15 min at room temperature.
- During incubation, replace the media of each plate with 20mL of DMEM + 10% NuSerum + 1% Penicillin-Streptomycin.
- Add 5mL of transfection mixture to each plate. Rock plates to mix and return to incubator.
24 hours post-transfection:
- Replace media of each plate with 25mL of DMEM + 1% Penicillin-Streptomycin (no serum).
72 hours post-transfection:
- Collect media from each plate in 50mL tubes (total volume ~125mL) while minimizing dislodging of cells. Centrifuge media at 600 x g for 10 min to pellet cells.
- Filter supernatant into a vacuum container with 0.45um pore size.
- Move collected supernatant to 4 deg and place on a magnetic stir plate.
- Slowly add 2.92g of NaCl to mixture while stirring for a final concentration of 0.4 M.
- Slowly add 10.63g of PEG-8000 to mixture for a for a final concentration of 8.5%. Stir overnight.
- Centrifuge mixture at 7000 x g for 10 min to precipitate proteins including AAV capsids. A pellet may or may not be visible.
- Resuspend pellet or expected location of pellet in 13.5mL of lysis buffer (see buffers below).
- Add 13.5uL of benzonase to lysis mixture and incubate at 37 deg for 30 min.
- During incubation, prepare the iodixanol gradient. In a 36.2mL OptiSeal tube, add in order: 6mL of iodixanol solution A, 6mL of iodixanol solution B, 5mL of iodixanol solution C, and 6mL of iodixanol solution D (see buffers below). Slowly add each to the bottom of the tube while minimizing disruption of layers. We recommend using a 10mL Luer-lock syringe and a blunt-ended Hamilton needle for this.
- Following benzonase treatment, filter the lysis mixture through a 0.22um membrane.
- Gently add lysis mixture on top of the iodixanol gradient.
- Ultracentrifuge the iodixanol gradient at 200,000 x g for 90 min at 16 deg.
- Using an 18-gauge needle and 5mL Luer-lock syringe, collect 3-4mL of the clear 40% layer (iodixanol solution C) through the side of the tube.
- Add the collected 40% layer to a 15mL tube and fill to 15mL with PBS. Mix by inversion.
- Transfer the mixture into an Amicon Ultra-15 100kDa centrifuge tube. Centrifuge at 1900 x g for 15 min at 4 deg.
- Discard flow-through and add 14mL of PBS to top of centrifuge tube. Mix by inversion. Centrifuge again at 1900 x g for 15 min at 4 deg.
- Repeat step 16. To obtain higher titers, the length of centrifugation can be increased.
- Collect final volume (typically 50-200uL) of concentrated AAV vector. Aliquot and store at -80 deg.
Buffers:
- Lysis buffer (100mL): 3mL 5M NaCl + 2mL 1M tris + 95mL ddH2O
- Iodixanol solution A (50mL, colorless): 5mL 10x PBS + 50uL 1M MgCl2 + 125uL KCl + 10mL 5M NaCl + 12.5mL OptiPrep + 22.3mL ddH2O
- Iodixanol solution B (50mL, red): 5mL 10x PBS + 50uL 1M MgCl2 + 125uL KCl + 20mL OptiPrep + 100uL phenol red + 24.7mL ddH2O
- Iodixanol solution C (50mL, colorless): 5mL 10x PBS + 50uL 1M MgCl2 + 125uL KCl + 33.3mL OptiPrep + 11.5mL ddH2O
- Iodixanol solution D (50mL, yellow): 50uL 1M MgCl2 + 125uL KCl + 50mL OptiPrep + 25uL phenol red
Copyright: Content may be subjected to copyright.
How to cite:Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
- Wang, S K and Cepko, C L(2021). AAV vector production. Bio-protocol Preprint. bio-protocol.org/prep1211.
- Wang, S. K., Xue, Y. and Cepko, C. L.(2020). Microglia modulation by TGF-β1 protects cones in mouse models of retinal degeneration. The Journal of Clinical Investigation 130(8). DOI: 10.1172/JCI136160
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
Post a Question 0 Q&A